OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Khanani, Arshad M; Eichenbaum, David; Schlottmann, Patricio G; Tuomi, Lisa; Sarraf, David

Khanani, Arshad M; Eichenbaum, David; Schlottmann, Patricio G; Tuomi, Lisa; Sarraf, David.

Affiliation

Khanani AM; Sierra Eye Associates, Reno, Nevada.
Eichenbaum D; Retina Vitreous Associates of Florida, Tampa, Florida.
Schlottmann PG; Department of Ophthalmology, Morsani College of Medicine, University of South Florida, Tampa, Florida.
Tuomi L; Organizacion Medica de Investigacion, Buenos Aires, Argentina.
Sarraf D; Genentech, Inc, South San Francisco, California.

Retina ; 38(11): 2103-2117, 2018 Nov.

Article in En | MEDLINE | ID: mdl-29697591

Subject(s)

Bevacizumab/administration & dosage; Ranibizumab/administration & dosage; Retinal Detachment/drug therapy; Wet Macular Degeneration/complications; Angiogenesis Inhibitors/administration & dosage; Fluorescein Angiography; Humans; Intravitreal Injections; Retinal Detachment/diagnosis; Retinal Detachment/etiology; Retinal Pigment Epithelium/pathology; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Visual Acuity; Wet Macular Degeneration/diagnosis; Wet Macular Degeneration/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Detachment / Wet Macular Degeneration / Bevacizumab / Ranibizumab Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Retina Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google